Evaluation of Medium Chain Triglycerides in a Mixed Racial Population of Patients: a Feasibility Study
Completed · Not applicable
Conditions studied: Insulin Resistance
In brief
The study team will investigate the racial differences in the metabolic and clinical responses to Medium chain triglycerides (MCT) between African American and Caucasian American subjects.
Key facts
- Study ID
- NCT02783703
- Run by
- Boston Medical Center
- People needed
- 24
- Starts
- 2017-04-28
- Expected to finish
- 2018-06-20
- Last updated by the study team
- 2019-05-30
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- English-speaking
- Males and female ambulatory subjects
- Self-identify as Caucasian/White or Black/African American
- Body Mass Index <=45
You may not qualify if…
- Diagnosis of type 2 diabetes or hemoglobin A1c >6.5
- Use of insulin, oral hypoglycemic, agents, or insulin-sensitizing agents
- Daily use of oral steroids
- Unstable weight within 3 months prior to baseline (e.g., weight gain or loss of >3%)
- Use of any weight loss medications or sex hormone therapy
- Daily use of psychotropic medications (for schizophrenia, bipolar disorder, obsessive compulsive disorder, posttraumatic stress disorder, psychotic disorder, mania)
- Chronic kidney disease, on dialysis or history of renal transplant
- Poorly controlled cardiovascular disease or congestive heart failure
- Severe peripheral vascular disease or severe liver disease
- Cancer
- A condition requiring use of oxygen such as severe chronic obstructive pulmonary disease
- Women who are pregnant, lactating, or actively trying to become pregnant
- Any cognitive or other disorders that may interfere with participation or ability to follow restrictions
- Abnormal TSH levels (<0.01 or >1.5x the upper limit)
- Weight >450 lb (205 kg) or height > 6'6"
- Severe claustrophobia
- Has had or is preparing for bariatric surgery (pre- or post-bariatric)
- Medically required use of anticoagulant therapies
- Current use of MCT oil
- Anemia (hemoglobin and/or hematocrit outside sex-specific normal ranges)
Where it is running
- Boston Medical Center — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.